D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 22,067 202 World Ranking 13909 National Ranking 7214
Biology and Biochemistry D-index 76 Citations 22,380 208 World Ranking 3135 National Ranking 1621

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Cytokine

David A. Frank focuses on Cancer research, Molecular biology, Signal transduction, STAT3 and Cell biology. David A. Frank has researched Cancer research in several fields, including Cytokine, Carcinogenesis, ABL, Gefitinib and breakpoint cluster region. His Molecular biology research integrates issues from Fusion gene and SH2 domain, Proto-oncogene tyrosine-protein kinase Src, Phosphorylation, Tyrosine phosphorylation.

His Signal transduction research is multidisciplinary, incorporating elements of Leukemia, Transcription and In vivo. His work deals with themes such as Transcription factor and STAT1, which intersect with STAT3. His studies in Cell biology integrate themes in fields like Antigen, Interleukin 2, Regulation of gene expression, Ciliary neurotrophic factor and FOXP3.

His most cited work include:

  • Regulation of Gliogenesis in the Central Nervous System by the JAK-STAT Signaling Pathway (859 citations)
  • Sp1 elements protect a CpG island from de novo methylation (660 citations)
  • The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors (624 citations)

What are the main themes of his work throughout his whole career to date?

David A. Frank mainly investigates Cancer research, STAT3, Transcription factor, Signal transduction and Cell biology. His Cancer research research incorporates elements of Carcinogenesis, Cancer, Breast cancer, Tyrosine kinase and STAT protein. His study looks at the relationship between Transcription factor and topics such as Gene expression, which overlap with Transcription.

His Signal transduction research includes elements of Kinase, Immunology and Autocrine signalling. His study in Cell biology is interdisciplinary in nature, drawing from both Cytokine, Interleukin 12, IL-2 receptor and Cellular differentiation. His Tyrosine phosphorylation study combines topics from a wide range of disciplines, such as Molecular biology and STAT1.

He most often published in these fields:

  • Cancer research (63.78%)
  • STAT3 (33.07%)
  • Transcription factor (30.31%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (63.78%)
  • STAT3 (33.07%)
  • Cancer (12.60%)

In recent papers he was focusing on the following fields of study:

Cancer research, STAT3, Cancer, Transcription factor and Cancer cell are his primary areas of study. His work on Myeloid leukemia as part of general Cancer research research is often related to Atovaquone, thus linking different fields of science. His research in the fields of STAT protein overlaps with other disciplines such as Pyrimethamine.

The various areas that he examines in his Cancer study include Tyrosine kinase, Signal transduction, Transcriptome and Oncology. His work investigates the relationship between Signal transduction and topics such as Tumor microenvironment that intersect with problems in Targeted therapy and Angiogenesis. His work in Transcription factor tackles topics such as Gene expression which are related to areas like Advanced ovarian cancer and Identification.

Between 2017 and 2021, his most popular works were:

  • IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. (62 citations)
  • The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer (37 citations)
  • Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells (27 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Cytokine

His primary scientific interests are in Cancer research, Myeloid leukemia, Gene knockdown, STAT3 and Breast cancer. His studies deal with areas such as Cancer, Leukemia, PI3K/AKT/mTOR pathway, Kinase and MCL1 as well as Cancer research. He combines subjects such as Myeloid, CHOP and Mechanistic target of rapamycin with his study of Myeloid leukemia.

His STAT3 study combines topics in areas such as Carcinogenesis, Cytotoxic T cell and Tumor microenvironment. His Carcinogenesis study frequently draws connections to other fields, such as Signal transduction. His work carried out in the field of Breast cancer brings together such families of science as Regulation of gene expression, Transcription factor, Gene and Gene expression.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Regulation of Gliogenesis in the Central Nervous System by the JAK-STAT Signaling Pathway

Azad Bonni;Yi Sun;Mireya Nadal-Vicens;Ami Bhatt.
Science (1997)

1161 Citations

Sp1 elements protect a CpG island from de novo methylation

M Brandeis;D Frank;I Keshet;Z Siegfried.
Nature (1994)

967 Citations

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors

Lauren L.C. Marotta;Vanessa Almendro;Vanessa Almendro;Andriy Marusyk;Michail Shipitsin.
Journal of Clinical Investigation (2011)

900 Citations

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

Emmanuel Zorn;Erik A. Nelson;Mehrdad Mohseni;Fabrice Porcheray.
Blood (2006)

828 Citations

Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants

Heidi Greulich;Tzu-Hsiu Chen;Tzu-Hsiu Chen;Whei Feng;Whei Feng;Pasi A Jänne;Pasi A Jänne.
PLOS Medicine (2005)

756 Citations

A candidate prostate cancer susceptibility gene at chromosome 17p.

Sean V. Tavtigian;Jacques Simard;David H F Teng;Vicki Abtin.
Nature Genetics (2001)

703 Citations

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.

Jack L. Arbiser;Marsha A. Moses;Cecilia A. Fernandez;Neil Ghiso.
Proceedings of the National Academy of Sciences of the United States of America (1997)

602 Citations

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.

Nadia Carlesso;David A. Frank;James D. Griffin.
Journal of Experimental Medicine (1996)

583 Citations

Whole exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

Juliann Chmielecki;Aimee M Crago;Mara Rosenberg;Rachael O'Connor.
Nature Genetics (2013)

482 Citations

CREB: A mediator of long-term memory from mollusks to mammals

David A. Frank;David A. Frank;Michael E. Greenberg;Michael E. Greenberg.
Cell (1994)

478 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David A. Frank

Jack L. Arbiser

Jack L. Arbiser

Emory University

Publications: 121

Richard Jove

Richard Jove

Nova Southeastern University

Publications: 51

Matthew Meyerson

Matthew Meyerson

Harvard University

Publications: 45

Kinichi Nakashima

Kinichi Nakashima

Kyushu University

Publications: 43

James D. Griffin

James D. Griffin

Harvard University

Publications: 41

Richard Moriggl

Richard Moriggl

University of Veterinary Medicine Vienna

Publications: 37

Sean V. Tavtigian

Sean V. Tavtigian

University of Utah

Publications: 36

Gautam Sethi

Gautam Sethi

National University of Singapore

Publications: 34

Lisa A. Cannon-Albright

Lisa A. Cannon-Albright

University of Utah

Publications: 31

Thomas L. Rothstein

Thomas L. Rothstein

Western Michigan University

Publications: 31

Yuquan Wei

Yuquan Wei

Sichuan University

Publications: 31

Howard Cedar

Howard Cedar

Hebrew University of Jerusalem

Publications: 31

John J. O'Shea

John J. O'Shea

National Institutes of Health

Publications: 31

Charles G. Mullighan

Charles G. Mullighan

St. Jude Children's Research Hospital

Publications: 30

Jennifer R. Grandis

Jennifer R. Grandis

University of California, San Francisco

Publications: 29

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 28

Trending Scientists

Han-Youl Ryu

Han-Youl Ryu

Inha University

Prabeer Barpanda

Prabeer Barpanda

Indian Institute of Science

Sara A. Majetich

Sara A. Majetich

Carnegie Mellon University

Steffen Porwollik

Steffen Porwollik

APEX Think Consulting

Teresa W.-M. Fan

Teresa W.-M. Fan

University of Kentucky

Antony Bacic

Antony Bacic

La Trobe University

Anthony I.S. Kemp

Anthony I.S. Kemp

University of Western Australia

Jagadish Shukla

Jagadish Shukla

George Mason University

Guy Schumann

Guy Schumann

University of Bristol

Maribeth Stolzenburg

Maribeth Stolzenburg

University of Mississippi

Paulin Coulibaly

Paulin Coulibaly

McMaster University

Christine Knaevelsrud

Christine Knaevelsrud

Freie Universität Berlin

Michael Becker

Michael Becker

IBM (United States)

Claudia Haferlach

Claudia Haferlach

Ludwig-Maximilians-Universität München

William T. Riley

William T. Riley

National Institutes of Health

R. Marshall

R. Marshall

University of Manchester

Something went wrong. Please try again later.